Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children’s Oncology Group Study

Patricia Chévez-Barrios,Ralph C. Eagle,Mark Krailo,Jin Piao,Daniel M. Albert,Yun Gao,Geeta K. Vemuganti,Mohammad Javed Ali,Vikas Khetan,Santosh G Honavar,Joan M. O'Brien,Ann Leahey,Katherine K. Matthay,Anna T. Meadows,Murali Chintagumpala

Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children’s Oncology Group Study

2019

Patricia Chévez-Barrios
Ralph C. Eagle
Mark Krailo
Jin Piao
Daniel M. Albert
Yun Gao
Geeta K. Vemuganti
Mohammad Javed Ali
Vikas Khetan
Santosh G Honavar
Joan M. O'Brien
Ann Leahey
Katherine K. Matthay
Anna T. Meadows
Murali Chintagumpala

PURPOSETo prospectively determine the prevalence of high-risk histopathologic features (HRFs) in patients with unilateral retinoblastoma who undergo enucleation and to evaluate the role of chemothe...

Keywords:

Oncology
Enucleation
Adjuvant
Unilateral Retinoblastoma
Medicine
Chemotherapy
Internal medicine
adjuvant chemotherapy
group study
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations